A Study to Evaluate MK-1045 (CN201) in Participants With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (MK-1045-001/CN201-101)

Clinical trial NCT06189391 · RECRUITING

Trial details

NCT number: NCT06189391
Sponsor: MSD R&D (China) Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Start date: 2021-03-16
Primary completion: 2028-09-30
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.